Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer
View/ Open
DOI
10.1007/s10549-020-06013-6
Journal
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Metadata
Show full item recordAuthors
Richman, J; Ring, A; Dowsett, M; Sestak, ICollections
- Centre for Cancer Prevention [1169]